Apr 20, 2026 06:39AM H.C. Wainwright Reiterates Buy Rating on Cardiff Oncology (CRDF)

Mar 26, 2026 11:04AM Craig-Hallum on Cardiff Oncology (CRDF): KOL Event Reinforces FOLFIRI Synergy

Mar 26, 2026 08:48AM William Blair stays Outperform on Cardiff Oncology (CRDF) despite adoption hurdles, dilution risks

Mar 26, 2026 06:49AM H.C. Wainwright Reiterates Buy Rating on Cardiff Oncology (CRDF)

Jan 28, 2026 06:45AM H.C. Wainwright Reiterates Buy Rating on Cardiff Oncology (CRDF)

Jan 5, 2026 08:54AM Noble Capital Starts Cardiff Oncology (CRDF) at Outperform

Dec 21, 2025 04:00AM Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026

Dec 9, 2025 12:48PM Sidoti Events, LLC's Year-End Virtual Investor Conference

Dec 9, 2025 12:48PM Sidoti Events, LLC's Year-End Virtual Investor Conference

Dec 9, 2025 12:48PM Sidoti Events, LLC's Year-End Virtual Investor Conference

Dec 9, 2025 12:48PM Sidoti Events, LLC's Year-End Virtual Investor Conference

Dec 8, 2025 04:06PM Cardiff Oncology presents leukemia trial data at ASH 2025

Nov 6, 2025 06:07PM Cardiff Oncology, Inc. (CRDF) Tops Q3 EPS by 4c

Aug 6, 2025 07:12AM Cardiff Oncology (CRDF) PT Lowered to $10 at H.C. Wainwright

Jul 29, 2025 05:04PM Cardiff Oncology, Inc. (CRDF) Misses Q2 EPS by 2c

Jul 8, 2025 07:33AM Ladenburg Thalmann Starts Cardiff Oncology (CRDF) at Buy

Jun 24, 2025 01:07AM Jefferies Starts Cardiff Oncology (CRDF) at Hold

Jun 17, 2025 04:05PM Cardiff Oncology (CRDF) Appoints Roger Sidhu as Chief Medical Officer, Announces Timing for the Next Update from the CRDF-004 Trial

Jun 2, 2025 04:06PM Cardiff Oncology (CRDF) Announces Positive Data from Investigator-Initiated Trial of Onvansertib in Combination with Paclitaxel

May 9, 2025 07:02AM Cardiff Oncology (CRDF) PT Raised to $18 at H.C. Wainwright

May 8, 2025 08:20PM Cardiff Oncology, Inc. (CRDF) Misses Q1 EPS by 1c

Apr 23, 2025 04:09PM Cardiff Oncology (CRDF) Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients

Apr 14, 2025 06:41AM Piper Sandler Assumes Cardiff Oncology (CRDF) at Overweight

Apr 3, 2025 07:20AM Lucid Capital Markets Starts Cardiff Oncology (CRDF) at Buy

Feb 28, 2025 08:09AM Cardiff Oncology (CRDF) PT Raised to $17 at H.C. Wainwright

Feb 27, 2025 04:19PM Cardiff Oncology (CRDF) Files Mixed Shelf

Jan 2, 2025 12:51PM Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'

Dec 13, 2024 07:34AM Cardiff Oncology (CRDF) PT Raised to $10 at Piper Sandler on Initial Trial Data

Dec 10, 2024 07:21AM Cardiff Oncology (CRDF) Prices Oversubscribed $40 Million Underwritten Registered Direct Offering

Dec 10, 2024 07:12AM Cardiff Oncology (CRDF) Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial

Nov 19, 2024 08:04AM Cardiff Oncology (CRDF) Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC

Nov 7, 2024 04:36PM Cardiff Oncology, Inc. (CRDF) Tops Q3 EPS by 2c

Aug 8, 2024 04:26PM Cardiff Oncology, Inc. (CRDF) Misses Q2 EPS by 1c